NCT02894398 Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant Status COMPLETED Phase PHASE2
NCT02890368 Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides Status TERMINATED Phase PHASE1
NCT02888938 Diagnosis of Structural Sacroiliitis in Patients With Suspicion of Spondyloarthritis (EchoSPA) Status UNKNOWN Phase N/A
NCT02883114 An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults. Status COMPLETED Phase PHASE1
NCT02880371 A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02879747 Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children Status COMPLETED Phase PHASE2/PHASE3
NCT02878785 Decitabine and Talazoparib in Untreated AML and R/R AML Status COMPLETED Phase PHASE1/PHASE2
NCT02871037 Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02863575 A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine Status COMPLETED Phase PHASE3
NCT02859142 Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation Status COMPLETED Phase PHASE4
NCT02856581 Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes Status TERMINATED Phase PHASE3
NCT02855177 A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects Status COMPLETED Phase PHASE1
NCT02854800 Smoking Cessation & Opioid Dependence Treatment Integration Status COMPLETED Phase PHASE2/PHASE3
NCT02850406 Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease Status TERMINATED Phase PHASE2
NCT02847650 Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease Status TERMINATED Phase PHASE2
NCT02841267 A Trial of PF-06252616 in Ambulatory Participants With LGMD2I Status COMPLETED Phase PHASE1/PHASE2